Lymphedema characteristics | Number of patients (14/101) (%) |
---|---|
Time in months from RP and LEL (median; IQR) | 23.8 (9.2–36.5) |
Time in months from RT and LEL (median; IQR) | 4 (-0.5-17.3) |
Type of LEL | |
Unilateral | 13 (92.8) |
Bilateral | 1 (7.2) |
Stage ISL | |
1 | 7 (50%) |
2 | 6 (42.8) |
3 | 1 (7.1) |
Pitting | 13 (12.8) |
Swelling | 7 (50) |
Tissue thickening | 2 (1.9) |
Right limb Volume (ml) (median;IQR) | 6 (3.9–6.5) |
Left limb Volume (ml) (median;IQR) | 4.9 (33.8–7.1) |
Volume differences (ml) (median;IQR) | 14.1 (12.3–20.5) |
Active therapy (n, %) | |
Yes | 9 (64.3%) |
No | 5 (35.7%) |
Type of Active therapy | |
Bandage | 4 (28.5) |
Lymphatic drainage | 4 (28.5) |
No therapy | 5 (35.7) |